BCMA/CD3 BsAb

BCMA-CD3 bispecific antibody

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BCMA/CD3 BsAb, covering 2024-12-20 to 2024-12-20. Get the full timeline:

Most recent: Clinical Trial Update: BCMA/CD3 BsAb in the Treatment of High-risk Smoldering Multiple Myeloma [NA]